References
- GuariguataLWhitingDRHambletonIBeagleyJLinnenkampUShawJEGlobal estimates of diabetes prevalence for 2013 and projections for 2035Diabetes Res Clin Pract201410313714924630390
- Mandereau-BrunoLDenisPFagot-CampagnaAFosse-EdorhSPrevalence of people pharmacologically treated for diabetes and territorial variations in France in 2012Bull Epidémiol Hebd201430–31493499
- AmielSADixonTMannRJamesonKHypoglycaemia in type 2 diabetesDiabet Med20082524525418215172
- BronMMarynchenkoMYangHYuAPWuEQHypoglycemia, treatment discontinuation, and costs in patients with type 2 diabetes mellitus on oral antidiabetic drugsPostgrad Med201212412413222314122
- BudnitzDSLovegroveMCShehabNRichardsCLEmergency hospitalizations for adverse drug events in older AmericansN Engl J Med20113652002201222111719
- MajumdarSRHemmelgarnBRLinMMcBrienKMannsBJTonelliMHypoglycemia associated with hospitalization and adverse events in older people: population-based cohort studyDiabetes Care2013363585359024089536
- LipskaKJRossJSWangYNational trends in US hospital admissions for hyperglycemia and hypoglycemia among Medicare beneficiaries, 1999 to 2011JAMA Intern Med20141741116112424838229
- AhrenBAre sulfonylureas less desirable than DPP-4 inhibitors as add-on to metformin in the treatment of type 2 diabetes?Curr Diab Rep201111839021243448
- DejagerSSchweizerAMinimizing the risk of hypoglycemia with vildagliptin: Clinical experience, mechanistic basis, and importance in type 2 diabetes managementDiabetes Ther20112516622127800
- HalimiSRaccahDSchweizerADejagerSRole of vildagliptin in managing type 2 diabetes mellitus in the elderlyCurr Med Res Opin2010261647165620441397
- SchweizerADejagerSFoleyJEShaoQKothnyWClinical experience with vildagliptin in the management of type 2 diabetes in a patient population ≥75 years: a pooled analysis from a database of clinical trialsDiabetes Obes Metab201113556421114604
- DejagerSSchweizerAIncretin therapies in the management of patients with type 2 diabetes mellitus and renal impairmentHosp Pract (1995)20124072122615074
- CharbonnelBSchweizerADejagerSCombination therapy with DPP-4 inhibitors and insulin in patients with type 2 diabetes mellitus: what is the evidence?Hosp Pract (1995)2013419310723680741
- AhrénBSchweizerADejagerSVildagliptin enhances islet responsiveness to both hyper- and hypoglycemia in patients with type 2 diabetesJ Clin Endocrinol Metab2009941236124319174497
- GökeBGallwitzBErikssonJHellqvistAGause-NilssonID1680C00001 InvestigatorsSaxagliptin is non-inferior to glipizide in patients with type 2 diabetes mellitus inadequately controlled on metformin alone: a 52-week randomised controlled trialInt J Clin Pract2010641619163120846286
- MatthewsDRDejagerSAhrénBVildagliptin add-on to metformin produces similar efficacy and reduced hypoglycaemic risk compared with glimepiride, with no weight gain: results from a 2-year studyDiabetes Obes Metab20101278078920649630
- NauckMAMeiningerGShengDTerranellaLSteinPPSitagliptin Study 024 GroupEfficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, compared with the sulfonylurea, glipizide, in patients with type 2 diabetes inadequately controlled on metformin alone: a randomized, double-blind, non-inferiority trialDiabetes Obes Metab2007919420517300595
- TuppinPde RoquefeuilLWeillARicordeauPMerlièreYFrench national health insurance information system and the permanent beneficiaries sampleRev Epidemiol Sante Publique20105828629020598822
- BlinPLassalleRDureau-PourninCInsulin glargine and risk of cancer: a cohort study in the French National Healthcare Insurance DatabaseDiabetologia20125564465322222504
- SabouretPDepret-BixioLCotteFEMariePBediraNBlinPSex differences in stroke prevention in atrial fibrillation in French primary care. Results of the AFIGP (Atrial Fibrillation In General Practice) DatabaseClin Res Cardiol201410388789324830515
- Haute Autorité de Santé Avis de la Comission de TransparenceGalvus, 10 Décembre 2008 Available from: www.has-sante.fr/portail/plugins/ModuleXitiKLEE/types/FileDocument/doXiti.jsp?id=c_749360Accessed June 8, 2015 French
- LipskaKJWartonEMHuangESHbA1c and risk of severe hypoglycemia in type 2 diabetes: the diabetes and aging studyDiabetes Care2013363535354223900589
- KrobotKJFerranteSADaviesMJLower risk of hypoglycemia with sitagliptin compared to glipizide when either is added to metformin therapy: a pre-specified analysis adjusting for the most recently measured HbA(1c) valueCurr Med Res Opin2012281281128722697277
- AhrénBFoleyJEDejagerSHigher risk of hypoglycemia with glimepiride versus vildagliptin in patients with type 2 diabetes is not driven by high doses of glimepiride: divergent patient susceptibilities?Diabetes Ther2014545946925230877
- PenfornisABourdel-MarchassonIQuereSDejagerSReal-life comparison of DPP4-inhibitors with conventional oral antidiabetics as add-on therapy to metformin in elderly patients with type 2 diabetes: the HYPOCRAS studyDiabetes Metab20123855055722996038
- SimonDDetournayBEschwegeEReal-life comparison of DPP4-inhibitors with conventional oral antidiabetics as add-on therapy to metformin in elderly patients with type 2 diabetes: the HYPOCRAS studyDiabetes Ther2014520722424729158
- MathieuCBarnettAHBrathHEffectiveness and tolerability of second-line therapy with vildagliptin vs other oral agents in type 2 diabetes: a real-life worldwide observational study (EDGE)Int J Clin Pract20136794795623961850
- FarngrenJPerssonMSchweizerAFoleyJEAhrénBGlucagon dynamics during hypoglycemia and food-re-challenge following treatment with vildagliptin in insulin-treated patients with type 2 diabetesDiabetes Obes Metab20141681281824612221
- FarngrenJPerssonMSchweizerAFoleyJEAhrénBVildagliptin reduces glucagon during hyperglycemia and sustains glucagon counter-regulation during hypoglycemia in type 1 diabetesJ Clin Endocrinol Metab2012973799380622855332
- LiatisSMylonaMKalopitaSHypoglycaemia requiring medical assistance in patients with diabetes: a prospective multicentre survey in tertiary hospitalsDiabetes Metab20154112613125468446
- NelsonJMDufrauxKCookPFThe relationship between glycemic control and falls in older adultsJ Am Geriatr Soc2007552041204417971138
- WhitmerRAKarterAJYaffeKQuesenberryCPJrSelbyJVHypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitusJAMA20093011565157219366776
- HsuPFSungSHChengHMAssociation of clinical symptomatic hypoglycemia with cardiovascular events and total mortality in type 2 diabetes: a nationwide population-based studyDiabetes Care20133689490023223349
- StahnAPistroschFGanzXRelationship between hypoglycemic episodes and ventricular arrhythmias in patients with type 2 diabetes and cardiovascular diseases: silent hypoglycemias and silent arrhythmiasDiabetes Care20143751652024041680
- McCoyRGVan HoutenHKZiegenfussJYShahNDWermersRASmithSAIncreased mortality of patients with diabetes reporting severe hypoglycemiaDiabetes Care2012351897190122699297
- MorganCLMukherjeeJJenkins-JonesSHoldenSECurrieCJCombination therapy with metformin plus sulphonylureas versus metformin plus DPP-4 inhibitors: association with major adverse cardiovascular events and all-cause mortalityDiabetes Obes Metab20141697798324762119
- FulcherGSingerJCastañedaRThe psychosocial and financial impact of non-severe hypoglycemic events on people with diabetes: two international surveysJ Med Econ20141775176125061766
- BarendseSSinghHFrierBMSpeightJThe impact of hypoglycaemia on quality of life and related patient-reported outcomes in type 2 diabetes: a narrative reviewDiabet Med20122929330221838763
- WildDvon MaltzahnRBrohanEChristensenTClausonPGonder-FrederickLA critical review of the literature on fear of hypoglycemia in diabetes: implications for diabetes management and patient educationPatient Educ Couns200768101517582726
- BrodMWoldenMChristensenTBushnellDMUnderstanding the economic burden of nonsevere nocturnal hypoglycemic events: impact on work productivity, disease management, and resource utilizationValue Health2013161140114924326167
- HillHAKleinbaumDGBias in Observational StudiesWiley StatsRef Statistics Reference Online2014 Available from: http://onlinelibrary.wiley.com/doi/10.1002/9781118445112.stat05111/abstractAccessed June 10, 2015
- CariouBFontainePEschwegeEFrequency and predictors of confirmed hypoglycaemia in type 1 and insulin-treated type 2 diabetes mellitus patients in a real-life setting: results from the DIALOG studyDiabetes Metab20154111612525465273